Condensed Statements of Income (Unaudited) (USD $)	3 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
Net sales	$ 2,620,834	$ 2,489,542
Cost of products sold	882,997	812,043
Gross profit	1,737,837	1,677,499
Selling, general and administrative expenses	1,392,869	1,387,901
Research and development expenses	15,720	121,837
Total operating expenses	1,408,589	1,509,738
Income from operations	329,248	167,761
Other income (expenses)
Other income		17,543
Interest expense	(475)	(34,558)
Loss from Medical Joint Venture	(130,523)
Loss from Education Joint Venture	(3,416)
Total other expenses, net	(134,414)	(17,015)
Net income	$ 194,834	$ 150,746
Net income
Basic	$ 0.01	$ 0.01
Diluted	$ 0.01	$ 0.01
Weighted average shares outstanding and to be issued -
Basic	17,787,352	16,351,894
Diluted	18,268,814	16,752,580